Menu

Blog

Archive for the ‘neuroscience’ category: Page 579

May 24, 2021

BREAKING! University of Oklahoma Study Indicates That SARS-CoV-2 Might Cause Serum Amyloid A (SAA) Amyloidosis And Even Alzheimer Ultimately!

Posted by in categories: biotech/medical, neuroscience

A new study by researchers from University of Oklahoma has found that the SARS-CoV-2 coronavirus could be causing a secondary medical condition known as Serum Amyloid A (SAA) Amyloidosis.

The proteins Serum amyloid A (SAA) are a family of apolipoproteins associated with high-density lipoprotein (HDL) in plasma. Different isoforms of SAA are expressed constitutively (constitutive SAAs) at different levels or in response to inflammatory stimuli (acute phase SAAs). These proteins are produced predominantly by the liver.

May 23, 2021

Relational Processes in Ayahuasca Groups of Palestinians and Israelis

Posted by in categories: media & arts, neuroscience

“This study seeks to explore the potential role of the psychoactive brew ayahuasca in settings of intergroup contact to shift the awareness and attitudes related to the relations between groups embedded in ethnopolitical conflicts, including long-term disputes between Jewish Israelis and Palestinians. By doing so, the present study also seeks to 1) understand how psychedelics can affect relational and group-participatory processes and 2) expand knowledge on dynamics between these two groups by focusing on their interactions in a psychedelic group setting.”


Psychedelics are used in many group contexts. However, most phenomenological research on psychedelics is focused on personal experiences. This paper presents a phenomenological investigation centered on intersubjective and intercultural relational processes, exploring how an intercultural context affects both the group and individual process. Through 31 in-depth interviews, ceremonies in which Palestinians and Israelis drink ayahuasca together have been investigated. The overarching question guiding this inquiry was how psychedelics might contribute to processes of peacebuilding, and in particular how an intercultural context, embedded in a protracted conflict, would affect the group’s psychedelic process in a relational sense. Analysis of the interviews was based on grounded theory. Three relational themes about multilocal participatory events which occurred during ayahuasca rituals have emerged from the interviews: 1) Unity-Based Connection – collective events in which a feeling of unity and ‘oneness’ is experienced, whereby participants related to each other based upon a sense of shared humanity, and other social identities seemed to dissolve (such as national and religious identities). 2) Recognition and Difference-Based Connection – events where a strong connection was made to the other culture. These events occurred through the expression of the other culture or religion through music or prayers, which resulted in feelings of awe and reverence 3) Conflict-related revelations – events where participants revisited personal or historical traumatic elements related to the conflict, usually through visions. These events were triggered by the presence of ‘the Other,’ and there was a political undertone in those personal visions. This inquiry has revealed that psychedelic ceremonies have the potential to contribute to peacebuilding. This can happen not just by ‘dissolution of identities,’ but also by providing a space in which shared spiritual experiences can emerge from intercultural and interfaith exchanges. Furthermore, in many cases, personal revelations were related to the larger political reality and the history of the conflict. Such processes can elucidate the relationship between personal psychological mental states and the larger sociopolitical context.

Those who experience do not participate in the world. For the experience is “in them” and not between them and the world.”

Continue reading “Relational Processes in Ayahuasca Groups of Palestinians and Israelis” »

May 23, 2021

The women possibly at higher risk for Covid-19 that no one is talking about

Posted by in categories: biotech/medical, neuroscience

Last July, when her immediate family tested positive for Covid-19, Breanna Aguilar did not fit into any groups considered at higher risk for severe disease.

She is 31 years old, a pet sitter and former fitness teacher who once ran a half marathon. She was, by most measures, healthy.

When Aguilar got Covid-19 she lost her sense of taste, had mild fevers and muscle weakness. She could barely keep anything down yet gained about 30 pounds. Later, she developed pelvic pain, cystic acne, breast tenderness, headaches, brain fog and extreme fatigue.

May 22, 2021

BCI decodes neural signals for handwriting

Posted by in categories: innovation, neuroscience

Researchers have, for the first time, decoded the neural signals associated with writing letters, then displayed typed versions of these letters in real time. They hope their invention could one day help people with paralysis communicate.

May 22, 2021

World’s smallest single-chip system can be injected into the body

Posted by in categories: computing, health, neuroscience

The continuing miniaturization of electronics is opening up some exciting possibilities when it comes to what we might place in our bodies to monitor and improve our health. Engineers at Columbia University have demonstrated an extreme version of this technology, developing the smallest single-chip system ever created, which could be implanted with a hypodermic needle to measure temperature inside the body, and possibly much more.

From ladybug-sized implants that track oxygen levels in deep body tissues to tiny “neural dust” sensors that monitor nerve signals in real time, scientists are making big steps when it comes to the functionality of tiny electronic devices. The implant developed by the Columbia Engineers breaks new ground as the world’s smallest single-chip system, which is a completely functional electronic circuit with a total volume of less than 0.1 mm3.

That makes it as small as a dust mite, and only visible under a microscope. The tiny chip required some outside-the-box thinking to make, particularly when it comes to the way it communicates and is powered.

May 21, 2021

Researchers discover a gene that could help prevent Alzheimer’s disease

Posted by in categories: biotech/medical, neuroscience

May 21, 2021

Faecal transplantation: the cure for forgetfulness?

Posted by in categories: biotech/medical, chemistry, life extension, neuroscience

In our ongoing search to continuously improve our health, we occasionally pay lip service to the bacteria that live inside our gut. Normally this concern rarely manifests as anything more than occasionally remembering to buy some of those small bottles of pro-biotic yoghurts while shopping for your…


Recent discoveries have led to the conclusion that the gut plays an important role in cognitive function, with a large amount of research into understanding what is known as the gut-brain axis, which is the collective name given to the biochemical signalling pathways which take place between the gastrointestinal tract and the central nervous system. With an ever-increasing understanding of this pathway, along with an expanded understand of the gut flora (which was found to decline with age), researchers started to ask how the gut flora are involved in the ageing process.

In order to test how exactly ageing gut flora effects the gut-brain axis, researchers at the University of East Anglia conducted a faecal transplant from elderly mice into younger mice. Following this transplant, the young mice were then put through a serious of tests to assess their cognitive abilities. The younger mice showed significant changes in their microbial profiles, as well as significantly impaired capacity for spatial learning, as well as a decreased capacity for memorisation. These mice also showed an altered expression of proteins associated with neurotransmission and neuroplasticity, along with changes in the mice’s hippocampus, which is responsible for allowing the mice to memories new information, as well as recalling previous memories.

Continue reading “Faecal transplantation: the cure for forgetfulness?” »

May 19, 2021

Study solves mystery of how amyloid beta forms in brain nerve cells

Posted by in categories: biotech/medical, neuroscience

In a major breakthrough, researchers at Massachusetts General Hospital (MGH) have discovered how amyloid beta—the neurotoxin believed to be at the root of Alzheimer’s disease (AD)—forms in axons and related structures that connect neurons in the brain, where it causes the most damage. Their findings, published in Cell Reports, could serve as a guidepost for developing new therapies to prevent the onset of this devastating neurological disease.

Among his many contributions to research on AD, Rudolph Tanzi, Ph.D., vice chair of Neurology and co-director of the McCance Center for Brain Health at MGH, led a team in 1986 that discovered the first Alzheimer’s disease gene, known as APP, which provides instructions for making protein precursor (APP). When this protein is cut (or cleaved) by enzymes—first, beta secretase, followed by gamma secretase—the byproduct is amyloid beta (sometimes shortened to Abeta). Large deposits of amyloid beta are believed to cause neurological destruction that results in AD. Amyloid beta formed in the brain’s axons and nerve endings causes the worst damage in AD by impairing communication between nerve cells (or neurons) in the brain. Researchers around the world have worked intensely to find ways to block the formation of amyloid beta by preventing cleavage by beta secretase and gamma secretase. However, these approaches have been hampered by safety issues.

Despite years of research, a major mystery has remained. “We knew that Abeta is made in the axons of the brain’s nerve cells, but we didn’t know how,” says Tanzi. He and his colleagues probed the question by studying the brains of mice, as well as with a research tool known as Alzheimer’s in a dish, a three-dimensional cell culture model of the disease created in 2014 by Tanzi and a colleague, Doo Yeon Kim, Ph.D. Earlier, in 2013, several other MGH researchers, including neurobiologist Dora Kovacs, Ph.D. (who is married to Tanzi), and Raja Bhattacharyya, Ph.D., a member of Tanzi’s lab, showed that a form of APP that has undergone a process called palmitoylation (palAPP) gives rise to amyloid beta. That study indicated that, within the neuron, palAPP is transported in a fatty vesicle (or sac) known as a lipid raft. But there are many forms of lipid rafts.

May 18, 2021

Brain-Computer Interface Translates Brain Signals Associated with Handwriting into Text

Posted by in categories: computing, information science, neuroscience

Researchers with the BrainGate Collaboration have deciphered the brain activity associated with handwriting: working with a 65-year-old (at the time of the study) participant with paralysis who has sensors implanted in his brain, they used an algorithm to identify letters as he attempted to write them; then, the system displayed the text on a screen; by attempting handwriting, the participant typed 90 characters per minute — more than double the previous record for typing with a brain-computer interface.

So far, a major focus of brain-computer interface research has been on restoring gross motor skills, such as reaching and grasping or point-and-click typing with a computer cursor.

May 17, 2021

Creating a safe CAR T-Cell therapy to fight solid tumors in children

Posted by in categories: biotech/medical, neuroscience

Scientists modify CAR T-Cell therapy, making it more effective and less toxic, for possible use in solid tumors such as neuroblastoma.


Chimeric Antigen Receptor T-cell therapy — CAR T — has revolutionized leukemia treatment. Unfortunately, the therapy has not been effective for treating solid tumors including childhood cancers such as neuroblastoma. Preclinical studies using certain CAR T against neuroblastoma revealed toxic effects. Now, a group of scientists at Children’s Hospital Los Angeles have developed a modified version of CAR T that shows promise in targeting neuroblastoma, spares healthy brain tissue and more effectively kills cancer cells. Their study was published today in Nature Communications. While this work is in the preclinical phase, it reveals potential for lifesaving treatment in children and adults with solid tumors.

Shahab Asgharzadeh, MD, a physician scientist at the Cancer and Blood Disease Institute of CHLA, is working to improve the lifesaving CAR T-cell therapy, in which scientists take a patient’s own immune system T-cells and engineer them to recognize and destroy cancer cells.

“The CAR T therapy works in leukemia,” he says, “by targeting a unique protein (or antigen) on the surface of leukemia cells. When the treatment is given, leukemia cells are killed. CAR T turns the patient’s immune system into a powerful and targeted cancer-killer in patients with leukemia. This antigen is also on normal B cells in the blood, but this side effect can be treated medically.”

Page 579 of 1,030First576577578579580581582583Last